Truist Financial Cuts UiPath (NYSE:PATH) Price Target to $12.00

UiPath (NYSE:PATHGet Free Report) had its price objective reduced by equities research analysts at Truist Financial from $17.00 to $12.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Truist Financial’s price objective would suggest a potential upside of 3.33% from the company’s current price.

Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group cut their target price on shares of UiPath from $19.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday. Bank of America lowered their price target on shares of UiPath from $14.00 to $12.00 and set an “underperform” rating on the stock in a report on Thursday. DA Davidson reduced their price objective on UiPath from $15.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of UiPath in a research report on Monday, December 29th. Finally, UBS Group reiterated a “neutral” rating and set a $13.00 target price on shares of UiPath in a research note on Thursday. Two analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $14.27.

Get Our Latest Stock Analysis on PATH

UiPath Price Performance

NYSE PATH traded down $0.77 during trading on Thursday, reaching $11.61. 66,733,772 shares of the company’s stock were exchanged, compared to its average volume of 34,541,016. The business has a 50 day moving average price of $13.15 and a 200-day moving average price of $13.99. The stock has a market capitalization of $6.21 billion, a P/E ratio of 27.65, a PEG ratio of 1.58 and a beta of 1.09. UiPath has a fifty-two week low of $9.38 and a fifty-two week high of $19.84.

UiPath (NYSE:PATHGet Free Report) last issued its earnings results on Wednesday, March 11th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.25 by $0.05. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The company had revenue of $481.11 million during the quarter, compared to the consensus estimate of $464.81 million. During the same period in the previous year, the company posted $0.26 EPS. The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year. On average, analysts forecast that UiPath will post -0.17 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Daniel Dines sold 45,000 shares of the company’s stock in a transaction on Monday, January 26th. The stock was sold at an average price of $15.01, for a total transaction of $675,450.00. Following the completion of the sale, the chief executive officer directly owned 27,893,585 shares in the company, valued at approximately $418,682,710.85. This represents a 0.16% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Ashim Gupta sold 67,468 shares of the stock in a transaction on Monday, January 5th. The stock was sold at an average price of $16.10, for a total value of $1,086,234.80. Following the sale, the chief financial officer directly owned 557,028 shares in the company, valued at approximately $8,968,150.80. This trade represents a 10.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 832,468 shares of company stock valued at $13,668,235. 23.19% of the stock is owned by company insiders.

Institutional Investors Weigh In On UiPath

Large investors have recently bought and sold shares of the company. Corient Private Wealth LLC grew its position in UiPath by 5.6% in the fourth quarter. Corient Private Wealth LLC now owns 27,283 shares of the company’s stock valued at $447,000 after acquiring an additional 1,455 shares during the last quarter. Avory & Company LLC bought a new position in shares of UiPath in the fourth quarter worth about $275,000. Invesco Ltd. lifted its holdings in shares of UiPath by 32.1% in the fourth quarter. Invesco Ltd. now owns 1,202,277 shares of the company’s stock worth $19,705,000 after acquiring an additional 292,134 shares during the last quarter. Mercer Global Advisors Inc. ADV boosted its stake in shares of UiPath by 31.4% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 38,330 shares of the company’s stock valued at $619,000 after purchasing an additional 9,151 shares in the last quarter. Finally, Skyview Financial Group LLC acquired a new stake in shares of UiPath in the 4th quarter valued at approximately $2,794,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Key UiPath News

Here are the key news stories impacting UiPath this week:

  • Positive Sentiment: Q4 beat, rising margins and first GAAP profit — UiPath reported revenue of $481.1M (+13.5% y/y) and EPS of $0.30, topping estimates and showing improved profitability. UiPath margins shine as AI fuels growth
  • Positive Sentiment: $500M share buyback announced — management authorized a $500M repurchase program, which supports per‑share metrics and can be a near‑term share‑price tailwind. UiPath stock: why sell-off makes sense despite Q4 beat and buyback
  • Neutral Sentiment: FY‑27 revenue guide mixed — UiPath guided FY‑27 revenue around $1.8B (above some estimates) but the implied growth rate slows to roughly ~10%, a core reason investors pulled back. UiPath Guides for Slower Full-Year Revenue Growth
  • Neutral Sentiment: Heavy volume and unusual options flow — trading is well above average and large call buying was reported, indicating both conviction and increased short‑term volatility. Benzinga options/volume note
  • Negative Sentiment: Market reacted to a tempered outlook and slower acceleration — despite beats, investors punished PATH because the full‑year cadence implies deceleration versus prior trends. UiPath: Fine Q4 Earnings, But The Bull Case Remains Uninspiring
  • Negative Sentiment: Analyst price‑target cuts and neutral/equal‑weight ratings — multiple shops trimmed targets (DA Davidson, Wells Fargo, Mizuho) or set neutral ratings, which reduces buy‑side momentum. Benzinga analyst updates
  • Negative Sentiment: AI worries: analysts say AI narrative hasn’t yet driven faster growth — commentary from UBS/Morgan Stanley and press pieces highlight investor skepticism that AI adoption will quickly re‑accelerate revenue. AI concerns coverage
  • Negative Sentiment: Immediate market move: shares slid (reports ~6% intraday) after the print, reflecting the gap between operational progress and investor growth expectations. UiPath Stock Sinks 6% — But It Could Still Be the Next Palantir

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Featured Articles

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.